Company Active LTD

Company profile

Visbion Ltd

Visbion Ltd is a UK company with status active founded in 2006.

CRN
05731554
Founded
2006
Age
20

Overview

Legal name
VISBION LTD
Region
Unknown
Registered address
1 FIRST FLOOR OFFICES, SUITE 3, 1 DUCHESS STREET
LONDON
ENGLAND
W1W 6AN
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Visbion Ltd
CRN 05731554
2
Direct and ultimate controller Active LTD
Biotronics 3D Limited
CRN 05029338

Company events

Reference milestones and recent Companies House filing stream events.

9 events
20 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

06 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

14 Aug
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzMjEyMzQzNGFkaXF6a2N4

Published 14 Aug 2024 08:49

14 Aug
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzMjEyMzMzNmFkaXF6a2N4

Published 14 Aug 2024 08:48

14 Aug
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzMjEyMzI2OGFkaXF6a2N4

Published 14 Aug 2024 08:47

13 Aug
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzMTUxNjM0NWFkaXF6a2N4 | Paper/PDF filed

Published 14 Aug 2024 07:56

06 Mar
2006

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2015
Funded years
2015, 2020
Age at first award
9 years

Projects

2020 Feasibility Studies Lead participant

Visbion Image Cube CT Enhancement Project

1 Jun 2020 to 30 Nov 2020

Awarded
£45,661
Total cost £45,661

The coronavirus crisis has emphasised the need for integrated and flexible healthcare provision. The NHS is an extremely well-integrated organisation, which under normal circumstances, provides excellent healthcare to the nation. However, in the current circumstances there is a need for greater flexibility in the deployment of resources for specific needs...

2015 GRD Development of Prototype Lead participant

A comprehensive web-based broker system for biotechnology design and manufacturing

1 Jun 2015 to 31 May 2017

Awarded
£250,000
Total cost £596,292

In order to manufacture many biological products at scale it is first necessary digitally to design the products so that they can be made using standard parts and automated processes. There are a number of digital parts (‘bioparts’) registries, consumables libraries, and biological design tools (‘bioCAD’ tools) becoming available for use by a broad range ...

Product types

Feasibility Studies GRD Development of Prototype